Pharmaceutical
- All
- News
- Videos
- Photos
-
No Brand Names, Prescribing Generic Drugs Should Be A Must: Supreme Court
Doctors should only prescribe generic medicines and not any particular brand, as has been ordered in Rajasthan, the Supreme Court remarked today while hearing a petition seeking regulation of unethical marketing practices by pharmaceutical companies.
-
AstraZeneca Moves Some Production To US Amid Tariff Threat
British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.
-
Pakistan Scrambles To Secure Drug Supplies After India Trade Halt: Report
Pakistani health authorities have initiated "emergency preparedness" measures to secure pharmaceutical supplies in response to the suspension of trade ties with India, according to a media report on Saturday.
-
Mumbai-Born US CEO Reshma Kewalramani Named In TIME's 2025 Influential List
Reshma Kewalramani, the Indian-origin CEO of US-based Vertex Pharmaceuticals, has been named on the list of "100 Most Influential People" of 2025 by Time Magazine.
-
Trump Sets Stage For New Tariffs With Probe Into Pharma, Chip Imports
Amid US President Donald Trump's fresh tariff threats, the federal government in America has opened an investigation into the effects of importing certain pharmaceuticals and semiconductors on national security.
-
US Opens Door To Tariffs On Pharma, Semiconductors
The United States opened the door Monday to tariffs targeting high-end technology and pharmaceuticals, feeding the uncertainty gripping the global economy in a trade war that Chinese leader Xi Jinping warned can have "no winner."
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
Sensex, Nifty Open In Red Ahead Of Repo Rate Announcement
Indian equity indices opened in the red on Wednesday, following its global peers, as US President Donald Trump threatened reciprocal tariffs on the global pharmaceutical sector.
-
New Trouble For India? Trump Says US Will Tariff Pharmaceutical Imports Soon
Continuing his economic onslaught, US President Donald Trump said on Tuesday that Washington is planning to announce a "major" tariff on pharmaceutical imports soon.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Here Are Trump's Reciprocal Tariffs By Country. Topping List At 50% Are...
Certain goods from key industries - including steel, aluminum, automobiles, copper, pharmaceuticals, semiconductors, and lumber - are exempt from these rates.
-
"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections
The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and girls 12 and older.
-
15 Lakh Bottles Of ADHD Medication Recalled In U.S. By Glenmark
ADHD is seen as a chronic and incapacitating disorder that affects a person's everyday functioning.
-
India Bans Two Addictive Opioids Amid Misuse In West Africa
The drugs were being illegally exported to West African countries by Mumbai-based Aveo Pharmaceuticals
-
Donald Trump Plans To Impose New Tariffs "Over Next Month". What's On Target
US President Donald Trump is planning to announce tariffs on more products as he pushes to shrink America's trade deficits, boost domestic manufacturing and achieve other policy goals.
-
No Brand Names, Prescribing Generic Drugs Should Be A Must: Supreme Court
Doctors should only prescribe generic medicines and not any particular brand, as has been ordered in Rajasthan, the Supreme Court remarked today while hearing a petition seeking regulation of unethical marketing practices by pharmaceutical companies.
-
AstraZeneca Moves Some Production To US Amid Tariff Threat
British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.
-
Pakistan Scrambles To Secure Drug Supplies After India Trade Halt: Report
Pakistani health authorities have initiated "emergency preparedness" measures to secure pharmaceutical supplies in response to the suspension of trade ties with India, according to a media report on Saturday.
-
Mumbai-Born US CEO Reshma Kewalramani Named In TIME's 2025 Influential List
Reshma Kewalramani, the Indian-origin CEO of US-based Vertex Pharmaceuticals, has been named on the list of "100 Most Influential People" of 2025 by Time Magazine.
-
Trump Sets Stage For New Tariffs With Probe Into Pharma, Chip Imports
Amid US President Donald Trump's fresh tariff threats, the federal government in America has opened an investigation into the effects of importing certain pharmaceuticals and semiconductors on national security.
-
US Opens Door To Tariffs On Pharma, Semiconductors
The United States opened the door Monday to tariffs targeting high-end technology and pharmaceuticals, feeding the uncertainty gripping the global economy in a trade war that Chinese leader Xi Jinping warned can have "no winner."
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
Sensex, Nifty Open In Red Ahead Of Repo Rate Announcement
Indian equity indices opened in the red on Wednesday, following its global peers, as US President Donald Trump threatened reciprocal tariffs on the global pharmaceutical sector.
-
New Trouble For India? Trump Says US Will Tariff Pharmaceutical Imports Soon
Continuing his economic onslaught, US President Donald Trump said on Tuesday that Washington is planning to announce a "major" tariff on pharmaceutical imports soon.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Here Are Trump's Reciprocal Tariffs By Country. Topping List At 50% Are...
Certain goods from key industries - including steel, aluminum, automobiles, copper, pharmaceuticals, semiconductors, and lumber - are exempt from these rates.
-
"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections
The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and girls 12 and older.
-
15 Lakh Bottles Of ADHD Medication Recalled In U.S. By Glenmark
ADHD is seen as a chronic and incapacitating disorder that affects a person's everyday functioning.
-
India Bans Two Addictive Opioids Amid Misuse In West Africa
The drugs were being illegally exported to West African countries by Mumbai-based Aveo Pharmaceuticals
-
Donald Trump Plans To Impose New Tariffs "Over Next Month". What's On Target
US President Donald Trump is planning to announce tariffs on more products as he pushes to shrink America's trade deficits, boost domestic manufacturing and achieve other policy goals.
